Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Leroy

Showing results (71-80 of 148) with videos related to

Pageof 15
Sort By:
Shock (Augusta, Ga.)|April 17, 2004
Massive alveolar thrombin activation in Pseudomonas aeruginosa-induced acute lung injuryEric Kipnis, Benoît P Guery, Antoine Tournoys, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2013
Evolution of novel tricyclic CRTh2 receptor antagonists from a (E)-2-cyano-3-(1H-indol-3-yl)acrylamide scaffoldAnja Valdenaire, Julien Pothier, Dorte Renneberg, et al.
Histopathology|January 3, 2014
Clear cell papillary renal cell carcinoma is an indolent and low-grade neoplasm with overexpression of cyclin-D1Xavier Leroy, Philippe Camparo, Viviane Gnemmi, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 16, 2005
[Is tumour grade applicable to finasteride-treated prostate cancer?]Vincent Molinié, Alain Ruffion, Yves Allory, et al.
BMC Cancer|April 18, 2015
Improvement of the initial management of sarcomas after the dissemination of evidence-based guidelines depends on the primary sarcoma location: a population-based studyKarine Ligier, Carlos Maynou, Xavier Leroy, et al.
The American Journal of Surgical Pathology|March 27, 2003
MUC6 is a marker of seminal vesicle-ejaculatory duct epithelium and is useful for the differential diagnosis with prostate adenocarcinomaXavier Leroy, Charles Ballereau, Arnauld Villers, et al.
Annales De Pathologie|June 1, 2006
[Weiss system: a still in-use diagnostic tool for the assessment of adrenocortical malignancy]Sébastien Aubert, David Buob, Xavier Leroy, et al.
Urology|October 11, 2003
Quantitative RT-PCR assay for MUC3 and VEGF mRNA in renal clear cell carcinoma: relationship with nuclear grade and prognosisXavier Leroy, Valerie Gouyer, Charles Ballereau, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2002
Morphologic subtyping of papillary renal cell carcinoma: correlation with prognosis and differential expression of MUC1 between the two subtypesXavier Leroy, Laurent Zini, Emmanuelle Leteurtre, et al.
Oncotarget|January 6, 2017
TMPRSS2-ERG fusion promotes prostate cancer metastases in boneRachel Deplus, Carine Delliaux, Nathalie Marchand, et al.
Pageof 15

Showing results (71-80 of 148) with videos related to

Sort By:
Pageof 15
Shock (Augusta, Ga.)|April 17, 2004
Massive alveolar thrombin activation in Pseudomonas aeruginosa-induced acute lung injuryEric Kipnis, Benoît P Guery, Antoine Tournoys, et al.
Bioorganic & Medicinal Chemistry Letters|January 18, 2013
Evolution of novel tricyclic CRTh2 receptor antagonists from a (E)-2-cyano-3-(1H-indol-3-yl)acrylamide scaffoldAnja Valdenaire, Julien Pothier, Dorte Renneberg, et al.
Histopathology|January 3, 2014
Clear cell papillary renal cell carcinoma is an indolent and low-grade neoplasm with overexpression of cyclin-D1Xavier Leroy, Philippe Camparo, Viviane Gnemmi, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie|August 16, 2005
[Is tumour grade applicable to finasteride-treated prostate cancer?]Vincent Molinié, Alain Ruffion, Yves Allory, et al.
BMC Cancer|April 18, 2015
Improvement of the initial management of sarcomas after the dissemination of evidence-based guidelines depends on the primary sarcoma location: a population-based studyKarine Ligier, Carlos Maynou, Xavier Leroy, et al.
The American Journal of Surgical Pathology|March 27, 2003
MUC6 is a marker of seminal vesicle-ejaculatory duct epithelium and is useful for the differential diagnosis with prostate adenocarcinomaXavier Leroy, Charles Ballereau, Arnauld Villers, et al.
Annales De Pathologie|June 1, 2006
[Weiss system: a still in-use diagnostic tool for the assessment of adrenocortical malignancy]Sébastien Aubert, David Buob, Xavier Leroy, et al.
Urology|October 11, 2003
Quantitative RT-PCR assay for MUC3 and VEGF mRNA in renal clear cell carcinoma: relationship with nuclear grade and prognosisXavier Leroy, Valerie Gouyer, Charles Ballereau, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 14, 2002
Morphologic subtyping of papillary renal cell carcinoma: correlation with prognosis and differential expression of MUC1 between the two subtypesXavier Leroy, Laurent Zini, Emmanuelle Leteurtre, et al.
Oncotarget|January 6, 2017
TMPRSS2-ERG fusion promotes prostate cancer metastases in boneRachel Deplus, Carine Delliaux, Nathalie Marchand, et al.
Pageof 15